97-6516. Bayer Corporation; Pesticide Tolerance Petition Filing  

  • [Federal Register Volume 62, Number 50 (Friday, March 14, 1997)]
    [Notices]
    [Pages 12182-12185]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-6516]
    
    
    
    [[Page 12182]]
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    [PF-717; FRL-5590-2]
    
    
    Bayer Corporation; Pesticide Tolerance Petition Filing
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Notice of filing.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This notice announces the filing of a pesticide petition 
    proposing regulations establishing tolerances for residues of the 
    pyrethroid cyfluthrin in or on the raw agricultural commodities (RACs) 
    group citrus, fruits and to establish a maximum residue limit for 
    cyfluthrin on citrus oil and dried pulp. This notice includes a summary 
    of the petition that was prepared by Bayer Corporation.
    
    DATES: Comments, identified by the docket control number [PF-717], must 
    be received on or before April 14, 1997.
    
    ADDRESSES: By mail, submit written comments to Public Response and 
    Program Resources Branch, Field Operations Division (7506C), Office of 
    Pesticide Programs, Environmental Protection Agency, 401 M St. SW., 
    Washington, DC 20460. In person, bring comments to Rm. 1132, CM #2. 
    1921 Jefferson Davis Highway, Arlington, VA 22202.
        Comments and data may also be submitted electronically be sending 
    electronic mail (e-mail) to: opp-docket@epamail.epa.gov. Electronic 
    comments must be submitted as an ASCII file avoiding the use of special 
    characters and any form of encryption. Comments and data will also be 
    accepted on disks in WordPerfect 5.1 file format or in ASCII file 
    format. All comments and data in electronic form must be identified by 
    docket control number [PF-717]. Electronic comments on this notice may 
    be filed online at many Federal Depository Libraries. Additional 
    information on electronic submissions can be found below this document.
        Information submitted as a comments concerning this document may be 
    claimed confidential by marking any part or all of that information as 
    ``Confidential Business Information'' (CBI). CBI should not be 
    submitted through e-mail. Information marked as CBI will not be 
    disclosed except in accordance with procedures set forth in 40 CFR part 
    2. A copy of the comment that does not contain CBI must be submitted 
    for inclusion in the public record. Information not marked confidential 
    may be disclosed publicly by EPA without prior notice. All written 
    comments will be available for public inspection in Rm. 1132 at the 
    address given above, from 8:30 a.m. to 4 p.m., Monday through Friday, 
    excluding legal holidays.
    
    FOR FURTHER INFORMATION CONTACT: By mail: George T. LaRocca, Product 
    Manager (PM) 13, Registration Division (7505C), Office of Pesticide 
    Programs, Environmental Protection Agency, 401 M St., SW., Washington, 
    DC 20460. Office location, telephone number, and e-mail address: Rm. 
    200, CM #2, 1921 Jefferson Davis Highway, Arlington, VA 22202. (703) 
    305-6100; larocca.george@epamail.epa.gov.
    
    SUPPLEMENTARY INFORMATION: EPA has received pesticide petitions (PP) 
    4F4313 and 4H5687 from Bayer Corporation, 8400 Hawthorn Road, Kansas 
    City, MO 64120. The petition proposes, pursuant to section 408(d) of 
    the Federal Food Drug and Cosmetic Act, 21 U.S.C. section 346a, to 
    amend 40 CFR 180.436 to establish tolerances for residues of the 
    insecticide cyfluthrin, [cyano[4-fluoro-3-phenoxyphenyl]-methyl-3-[2,2-
    dicloroethenyl]-2,2-dimethylcyclopropanecarboxylate] in or on the raw 
    agricultural commodities group citrus, fruits at 0.2 part per million 
    (ppm) and the processed commodities citrus, oil and citrus, dried pulp 
    at 0.3 part per million (ppm). The proposed analytical method is gas 
    chromatography equipped with electron capture detector.
        As required by section 408(d) of the FFDCA, as recently amended by 
    the Food Quality Protection Act, Bayer Corporation included in the 
    petition a summary of the petition and authorization for the summary to 
    be published in the Federal Register in a notice of receipt of the 
    petition. The summary represents the views of Bayer Corporation; EPA is 
    in the process of evaluating the petition. As required by section 
    408(d)(3) EPA is including the summary as a part of this notice of 
    filing. EPA may have made minor edits to the summary for the purpose of 
    clarity.
    
    I. Petition Summary
    
    A. Residue Chemistry
    
        1. Use pattern. Baythroid 2 will be used on citrus only in 
    California and Arizona, to control citrus thrips. A dosage of 6.4 fluid 
    ounces of Baythroid 2 (0.1 lb active ingredient per acre) will be 
    applied by ground equipment only, in sufficient water for complete 
    coverage of foliage in dilute or concentrate sprays, but not less than 
    25 gallons per acre. A single application may be made per season.
        2. Plant metabolism. The metabolism of cyfluthrin in plants is 
    adequately understood. Studies have been conducted to delineate the 
    metabolism of radiolabeled cyfluthrin in various crops all showing 
    similar results. The residue of concern is cyfluthrin.
        3. Analytical methodology. Adequate analytical methodology (Gas 
    liquid chromatography with an electron capture detector) is available 
    for enforcement purposes.
        The established tolerances for residues of cyfluthrin in/on eggs, 
    milks, fat, meat and meat by-products of cattle, goats, hogs, horses, 
    sheep and poultry are adequate to cover secondary residues resulting 
    from the proposed use as delineated in 40 CFR 180.6(a)(2).
        4. Magnitude of the residue. On December 20, 1993, Bayer Corp. 
    filed a petition (PP 4F4313) for a tolerance for residues of cyfluthrin 
    on the raw agricultural commodity, citrus and proposed food/feed 
    additive regulation (4H5687) for citrus oil, citrus dried pulp, and 
    citrus molasses under section 409 of FFDCA. A request was filed May 2, 
    1996, to withdraw the feed additive petition for citrus molasses, 
    submitted in response to EPA's determination that citrus molasses is no 
    longer considered a significant feed item. See EPA's final 860 Series 
    Residue Chemistry Guidelines (860.1000) published as public drafts on 
    August 25, 1995 (60 FR 44343) (formerly Table II of Subdivision O, 
    Residue Chemistry, of the Pesticide Assessment Guidelines).
        The food/feed additive petition for citrus oil and citrus dried 
    pulp has been revised to propose these tolerances at 0.3 ppm under 
    section 408 instead section 409 in accordance the Food Quality 
    Protection Act.
        The proposed section 408 tolerance for cyfluthrin on citrus is 0.2 
    ppm. The highest average residue found in crop field trials for 
    cyfluthrin on citrus fruits was 0.06 ppm. A processing study showed 
    that in producing citrus oil and dried pulp residues concentrated 530 
    (a concentration factor of 5.3 x ). Thus with this information it is 
    likely that cyfluthrin residues of 0.32 ppm (0.06  x  5.3) could occur 
    in citrus oil and dried pulp.
    
    B. Toxicological Profile
    
        The data base for cyfluthrin is essentially complete. Data lacking 
    but desirable are an acute neurotoxicity study in rats and a 90-day 
    neurotoxicity study in rats. Although these data are lacking, Bayer 
    Corp. believes there is sufficient toxicity data to support the 
    proposed tolerance and these missing data will not significantly change 
    the risk assessment. In a letter dated November 2, 1995, Bayer Corp. 
    has committed to submit the acute neurotoxicity study by December 1996
    
    [[Page 12183]]
    
    and the 90-day neurotoxicity study by May 1997.
        The toxicology data cited in support of the tolerance include:
        1. Chronic effects. A 12-month chronic feeding study in dogs with a 
    no-observed effect level (NOEL) of 4 mg/kg/day. The lowest effect level 
    (LEL) for this study is established at 16 mg/kg/day, based on slight 
    ataxia, increased vomiting, diarrhea and decreased body weight.
        A 24-month chronic feeding/carcinogenicity study in rats with a 
    NOEL of 2.5 mg/kg/day and LEL of 6.2 mg/kg/day, based on decreased body 
    weights in males, decreased food consumption in males, and inflammatory 
    foci in the kidneys in females.
        2. Acute toxicity. For the purposes of assessing acute dietary 
    risk, the Agency has used an oral developmental toxicity study in 
    rabbits with a maternal NOEL of 20 mg/kg/day and a maternal LEL of 60 
    mg/kg/day, based on decreased body weight gain and decreased food 
    consumption during the dosing period. A fetal NOEL of 20 mg/kg/day and 
    a fetal LEL of 60 mg/kg/day were also observed in this study. The LEL 
    was based on increased resorptions and increased postimplantation loss.
        3. Carcinogenicity. A 24-month carcinogenicity study in mice was 
    conducted. There were no carcinogenic effects observed under the 
    conditions of the study.
        A 24-month chronic feeding/carcinogenicity study in rats was 
    conducted. There were no carcinogenic effects observed under the 
    conditions of the study.
        Mutagenicity tests were conducted, including several gene mutation 
    assays (reverse mutation and recombination assays in bacteria and a 
    Chinese hamster ovary(CHO)/HGPRT assay); a structural chromosome 
    aberration assay (CHO/sister chromatid exchange assay); and an 
    unscheduled DNA synthesis assay in rat hepatocytes. All tests were 
    negative for genotoxicity.
        4. Other. A metabolism study in rats showed that cyfluthrin is 
    rapidly absorbed and excreted, mostly as conjugated metabolites in the 
    urine, within 48 hours. An enterohepatic circulation was observed.
    
    C. Aggregate Exposure
    
        A chronic dietary exposure/risk assessment was performed for 
    cyfluthrin using a Reference Dose (RfD) of 0.025 mg/kg bwt/day, based 
    on a NOEL of 50 ppm (2.5 mg/kg bwt/day) and an uncertainty factor of 
    100. The NOEL was determined in a 2-year rat feeding study. The 
    endpoint effects of concern were decreased body weights in males and 
    inflammation of the kidneys in females at the LEL of 6.2 mg/kg/day. For 
    purposes of this dietary exposure/risk assessment tolerance level 
    residues were used and percent crop treated assumption made for some of 
    the commodities. The current estimated dietary exposure for the overall 
    U.S. population resulting from established tolerances 0.009420 mg/kg/
    bwt/day or 37.6 percent of the RfD. The current estimated dietary 
    exposure for the subgroup population exposed to the highest risk, non-
    nursing infants less than 1 year old, 0.025266 mg/kg bwt/day or 101 
    percent of the RfD. Although the estimate of dietary exposure for the 
    subgroup, non-nursing infants less than 1 year old, is slightly higher 
    than the Agency's level of concern, i.e., greater than 100 percent of 
    the RfD, Bayer Corp. believes that actual exposure and risk would be 
    lower. The basis for this is that the risk reflects a higher than 
    actual dietary exposure because it assumes that 100 percent of most 
    commodities for which cyfluthrin tolerances exist have cyfluthrin 
    residues and that all will bear residue levels as high as the 
    tolerances. In reality, all these commodities will not have residues of 
    this pesticide and actual levels will be lower than tolerance levels. 
    To assess the dietary exposure from the establishment of the proposed 
    citrus tolerances, the incremental increase in dietary exposure was 
    taken from the dietary exposure analysis conducted by the Agency. These 
    estimates are based on the assumption that 100 percent of the citrus 
    crop in the U.S. would be treated with cyfluthrin. In reality, this use 
    of cyfluthrin will be limited to California and Arizona only for the 
    control of citrus thrips. For the prior six years, cyfluthrin has been 
    utilized in the California's Central Valley under the provisions of a 
    FIFRA section 18 Emergency Exemption. In 1995, approximately 77,000 out 
    of 170,000 acres (46 percent) of the citrus grown in Central Valley was 
    treated with cyfluthrin. Assuming that a similar proportion of acreage, 
    that is 46 percent, would be treated throughout California and Arizona, 
    the total estimated acreage treated with cyfluthrin would be 94,000 
    acres. This represents only 9.4 percent of the 1,026,000 fruit bearing 
    acres of citrus grown in the U.S. Therefore, a 10 percent treated crop 
    adjustment to the dietary exposure can be considered appropriate.
        Adding this incremental exposure to the current estimated dietary 
    exposure results in a total dietary exposure for the U.S. population of 
    0.0094934 mg/kg bwt/day representing 38 percent of RfD. The highest 
    exposure group, non-nursing infants will increase only very slightly, 
    to 0.253653 mg/kg bwt/day representing 101.4 percent of the RfD. As 
    described above, although this still slightly exceeds the RfD, actual 
    exposure is expected to be much less.
        Generally speaking, EPA has no cause for concern if the total 
    dietary exposure from residues for uses for which there are published 
    and proposed tolerances is less than the RfD. Therefore Bayer concludes 
    that the chronic dietary risk of cyfluthrin, as estimated by the 
    dietary risk assessment, does not appear to be of concern.
        Other potential sources of exposure to residues of pesticides are 
    residues in drinking water and exposure from non-occupational sources. 
    Based on available studies used in previous EPA assessments, Bayer 
    Corp. does not anticipate exposures to cyfluthrin in drinking water. 
    Non-occupational exposure to cyfluthrin may occur as a result of 
    inhalation or contact from indoor residential, indoor commercial, and 
    outdoor residential uses. The Agency does not currently have reliable 
    data to determine aggregate exposures from these sources. However, 
    determinations of worst case exposure from inhalation in indoor 
    settings (continuous exposure at saturation vapor concentration) should 
    indicate that adequate margins of safety exist even under these 
    conditions. Since this evaluation greatly overestimates exposure, the 
    contribution to aggregate exposure from inhalation in normal uses would 
    be expected to be negligible. Estimations of outdoor residential 
    exposure have been required for cyfluthrin in a data call-in issued in 
    1995. These data are being generated by the Outdoor Residential 
    Exposure Task Force (ORETF). However, available data show that the 
    acute dermal toxicity of cyfluthrin is very low, with the LD50 
    being greater than 5,000 mg/kg, the highest dose tested. Sub-acute (21-
    day) dermal toxicity data showed only localized (skin) effects at 
    higher level exposures (1,000 mg/kg/day and 340 mg/kg/day). Other than 
    skin effects at these high exposure levels, no effects were observed at 
    any exposure levels, the highest level tested being 1,000 mg/kg/day. 
    The use rate for cyfluthrin on residential turf is 1 g (1,000 mg) 
    active ingredient per 1000 square feet which would indicate that 
    potential exposures would be well below levels tested. In addition, the 
    localized skin effects seen at the prolonged higher exposures in animal 
    tests have not been reported for non-occupational exposures to 
    cyfluthrin in currently accepted uses,
    
    [[Page 12184]]
    
    indicating that exposures are below the threshold of any observable 
    effects. Indoor uses are limited to areas with little or no contact, so 
    exposures would be expected to be even less. Thus, the dermal route of 
    exposure does not appear to be significant and the contribution to 
    aggregate exposure from dermal contact would be expected to be 
    negligible.
        In consideration of potential cumulative effects of cyfluthrin and 
    other substances that have a common mechanism of toxicity, there are 
    currently no available data or other reliable information indicating 
    that any toxic effects produced by cyfluthrin would be cumulative with 
    those of other chemical compounds; thus only the potential risks of 
    cyfluthrin have been considered in this assessment of its aggregate 
    exposure.
    
    D. Safety Determinations
    
        1. U.S. population in general. Using the conservative exposure 
    assumptions described above and based on the completeness and 
    reliability of the toxicity data it can be concluded that total 
    aggregate exposure to cyfluthrin from all current uses as well as the 
    proposed tolerance and maximum residue levels for the use of cyfluthrin 
    on citrus will utilize little more than 38 percent of the RfD for the 
    U.S. population. EPA generally has no concerns for exposures below 100 
    percent of the RfD, because the RfD represents the level at or below 
    which daily aggregate exposure over a lifetime will not pose 
    appreciable risks to human health. Thus, it can be concluded that there 
    is a reasonable certainty that no harm will result from aggregate 
    exposure to cyfluthrin residues.
        2. Infants and children. In assessing the potential for additional 
    sensitivity of infants and children to residues of cyfluthrin, the data 
    from developmental studies in both rat and rabbit and a 2-generation 
    reproduction study in the rat can be considered. The developmental 
    toxicity studies evaluate any potential adverse effects on the 
    developing animal resulting from pesticide exposure of the mother 
    during prenatal development . The reproduction study evaluates any 
    effects from exposure to the pesticide on the reproductive capability 
    of mating animals through two generations, as well as any observed 
    systemic toxicity.
        The toxicology data cited in support of the tolerance include: An 
    oral developmental toxicity study in rats with a maternal and fetal 
    NOEL of 10 mg/kg/day (highest dose tested). An oral developmental 
    toxicity study in rabbits with a maternal NOEL of 20 mg/kg/day and a 
    maternal LEL of 60 mg/kg/day, based on decreased body weight gain and 
    decreased food consumption during the dosing period. A fetal NOEL of 20 
    mg/kg/day and a fetal LEL of 60 mg/kg/day were also observed in this 
    study. The LEL was based on increased resorptions and increased 
    postimplantation loss.
        A developmental toxicity study in rats by the inhalation route of 
    administration with a maternal NOEL of 0.0011 mg/l and a LEL of 0.0047 
    mg/l, based on reduced mobility, dyspnea, piloerection, ungroomed coats 
    and eye irritation. The fetal NOEL is 0.00059 mg/l and the fetal LEL is 
    0.0011 mg/l, based on sternal anomalies and increased incidence of 
    runts. A second developmental toxicity study in rats by the inhalation 
    route of administration has been submitted to the Agency and is 
    currently under review.
        A three-generation reproduction study in rats with a systemic NOEL 
    of 2.5 mg/kg/day and a systemic LEL of 7.5 mg/kg/day due to decreased 
    parent and pup body weights. The reproductive NOEL and LEL are 7.5 mg/
    kg/day and 22.5 mg/kg/day respectively.
        The Agency used the rabbit developmental toxicity study with a 
    maternal NOEL of 20 mg/kg/day to assess acute dietary exposure and 
    determine a margin of exposure (MOE) for the overall U.S. population 
    and certain subgroups. Since this toxicological endpoint pertains to 
    developmental toxicity the population group of concern for this 
    analysis was women aged 13 and above, the subgroup which most closely 
    approximates women of child-bearing age. The MOE is calculated as the 
    ration of the NOEL to the exposure. For this analysis the Agency 
    calculated the MOE to be over 600. Generally, MOE's greater than 100 
    for data derived from animal studies are regarded as showing no 
    appreciable risk.
        FFDCA Section 408 provides that EPA may apply an additional safety 
    factor for infants and children in the case of threshold effects to 
    account for pre- and post-natal effects and the completeness of the 
    toxicity database. Based on current toxicological data requirements, 
    the toxicology database for cyfluthrin relative to pre- and post-natal 
    effects is complete. The no-effect-levels observed in the developmental 
    and reproduction study are equivalent or higher than the NOEL from the 
    2-year rat feeding study, used with a 100 fold uncertainty factor to 
    establish the reference dose.
        Therefore, an additional uncertainty factor is not warranted and 
    that the RfD at 0.025 mg/kg/day is appropriate for assessing aggregate 
    risk to infants and children.
        Using the conservative exposure assumptions described above, EPA 
    has previously concluded that the residues from use of cyfluthrin on 
    citrus will contribute the highest incremental increase to the 
    aggregate exposure to the population subgroup children 1 to 6 years 
    old, accounting for 3.9 percent of the RfD and giving a total dietary 
    exposure from all uses of 95.9 percent of the RfD for this subgroup. 
    However, this assessment was based on an assumption of 100 percent crop 
    treated. When adjusted for a 10 percent crop treatment (as described in 
    section B. above) the incremental exposure is negligible, increasing 
    form the current 0.022985 mg/kg bwt /day (91.9 percent of the RfD) to 
    0.231522 mg /kg bwt/day or 92.6 percent of the RfD. For nursing infants 
    current exposure is 0.005692 mg/kg bwt/day or 22.8 percent of the RfD. 
    The use on citrus would increase exposure to 0.0057377 mg/kg bwt/day 
    representing 22.9 percent of the RfD. For children 7 to 12, current 
    exposure is 0.015237 mg/kg bwt/ day, 60.9 percent of the RfD. The use 
    on citrus would increase this to 0.153416 mg/kg bwt /day, or 61.4 
    percent of the RfD. For non-nursing infants, the current is exposure is 
    calculated to be 0.025267 mg/kg bwt /day, 101 percent of the RfD. The 
    use on citrus would increase this slightly to 0.0253653 or 101.4 
    percent. Both the current and the resulting calculated exposure from 
    adding the estimated exposure from citrus exposure are slightly higher 
    than the Agency's level of concern. However, the Agency has previously 
    assessed this risk in the evaluation of PP 2F4137 and believed the 
    actual exposure and risk would be much lower. The basis for this was 
    the fact that this calculated exposure assumes, with the exception of 
    citrus, that 100 percent of the commodities for which cyfluthrin 
    tolerance exists have residues and that the residues all bear residues 
    as high as the tolerance levels. In reality, it is known that not all 
    commodities will have cyfluthrin residues and actual levels will be 
    lower than the tolerance values. In addition, the food commodity that 
    contributes most to this slight exceedence is milk, at 88.2 percent of 
    the RfD; 71.2 percent from milk fat and 17 percent from whole milk and 
    milk sugars. However, metabolism data indicate that essentially all of 
    the cyfluthrin will concentrate in milk fat and there would be 
    negligible amounts in other components. Thus the 17 percent 
    contribution from non-milk fat portions of milk is an overestimation of 
    actual
    
    [[Page 12185]]
    
    exposure, which would be below the RfD.
        Generally, EPA has no cause for concern if the total aggregate 
    exposure is less than the RfD, therefore it may be concluded that there 
    is a reasonable certainty of no harm will result to infants and 
    children.
    
    E. Conclusions
    
        The available data indicate that there is reasonable certainty of 
    no harm from the incremental exposure resulting from the potential 
    residues of cyfluthrin from the use of Baythroid 2, EPA Reg. No. 3125-
    351, on citrus. Thus in accordance with the provisions of the FFDCA as 
    amended August 3, 1996, regulations to establish the tolerance and 
    maximum residue levels to support this use can be effected.
    
    F. International Tolerances
    
        There are no Codex maximum residue levels (MRLs) established for 
    residues ofcyfluthrin on citrus fruits or any resulting processed 
    products.
    
    II. Public Record
    
        Interested persons are invited to submit comments on this notice of 
    filing. Comments must bear a notation indicating the docket control 
    number, [PF-717]. All written comments filed in response to this 
    petition will be available in the Public Response and Program Resources 
    Branch, at the address given above from 8:30 a.m. to 4 p.m., Monday 
    through Friday, except legal holidays.
        A record has been established for this notice under docket control 
    number [PF-717] including comments and data submitted electronically as 
    described below). A public version of this record, including printed, 
    paper versions of electronic comments, which does not include any 
    information claimed as CBI, is available for inspection from 8:30 a.m. 
    to 4 p.m., Monday through Friday, excluding legal holidays. The public 
    record is located in Rm. 1132 of the Public Response and Program 
    Resources Branch, Field Operations Division (7506C), Office of 
    Pesticide Programs, Environmental Protection Agency, Crystal Mall #2, 
    1921 Jefferson Davis Highway, Arlington, VA.
        Electronic comments can be sent directly to EPA at:
        opp-docket@epamail.epa.gov
    
    
        Electronic comments must be submitted as ASCII file avoiding the 
    use of special characters and any form of encryption.
        The official record for this notice, as well as the public version, 
    as described above will be kept in paper form. Accordingly, EPA will 
    transfer all comments received electronically into printed, paper form 
    as they are received and will place the paper copies in the official 
    record which will also include all comments submitted directly in 
    writing. The official record is the paper record maintained at the 
    address in ``ADDRESSES'' at the beginning of this document.
    
        Authority: 21 U.S.C. 346a.
    
    List of Subjects
    
        Environmental Protection, Administrative practice and procedure, 
    Agricultural commodities, Pesticides and pests, Reporting and 
    recordkeeping requirements.
    
        Dated: March 7, 1997.
    
    Stephen L. Johnson,
    Director, Registration Division, Office of Pesticide Programs.
    
    [FR Doc. 97-6516 Filed 3-13-97; 8:45 am]
    BILLING CODE 6560-50-F
    
    
    

Document Information

Published:
03/14/1997
Department:
Environmental Protection Agency
Entry Type:
Notice
Action:
Notice of filing.
Document Number:
97-6516
Dates:
Comments, identified by the docket control number [PF-717], must be received on or before April 14, 1997.
Pages:
12182-12185 (4 pages)
Docket Numbers:
PF-717, FRL-5590-2
PDF File:
97-6516.pdf